Voyager Therapeutics (VYGR) Revenue (QoQ) (2015 - 2026)
Voyager Therapeutics (VYGR) Revenue (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83.13% |
| Dec 31, 2025 | 15.03% |
| Sep 30, 2025 | 157.02% |
| Jun 30, 2025 | -19.67% |
| Mar 31, 2025 | 2.73% |
| Dec 31, 2024 | -74.42% |
| Sep 30, 2024 | -16.73% |
| Jun 30, 2024 | 51.68% |
| Mar 31, 2024 | -78.36% |
| Dec 31, 2023 | 1,852.93% |
| Sep 30, 2023 | -5.84% |
| Jun 30, 2023 | -96.74% |
| Mar 31, 2023 | 9,808.39% |
| Dec 31, 2022 | -103.77% |
| Sep 30, 2022 | 5,670.51% |
| Jun 30, 2022 | 8.21% |
| Mar 31, 2022 | -97.66% |
| Dec 31, 2021 | 1,794.26% |
| Sep 30, 2021 | 9.21% |
| Jun 30, 2021 | -79.13% |